Markus W Büchler is an expert in Surgery at University Hospital Heidelberg (Germany). As of October 2026, ScienceLeadR ranks Markus W Büchler in the top 1% of experts worldwide for Pancreatic Diseases, Pancreatic Neoplasms and Pancreatitis. Markus W Büchler has authored 2,180 publications, the most recent in 2026, and is an investigator in 26 clinical trials, 1 of them ongoing. SLR score: 6,721 (community average: 125). How the SLR is computed.

LeadR Profile

Markus W Büchler University Hospital Heidelberg Germany
6 721 ScienceLeadR Reputation 6721
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1994 - 2026

Source: PubMed

University Hospital Heidelberg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 2180

Citations

Citations: 129 271 1st author: 41 Last author: 836 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Preoperative Injection of Botulinum Toxin Into the Sphincter of Oddi Does Not Prevent Pancreatic Fistula After Distal Pancreatectomy: The Randomized Controlled PREBOTPilot Trial.
PMID 42875865 — injections, fistula, sphincter of oddi, botulinum toxins, pancreatic fistula, general surgery, pancreatectomy
Ann Surg20260
Predictive Value of the ALBI Grade for Short-Term Morbidity and Mortality After Pancreatoduodenectomy.
PMID 42738417 — mortality, hyperbilirubinemia, pancreaticoduodenectomy, predictive value of tests, liver, morbidity, roc curve, postoperative complications, bilirubin, hypoalbuminemia
Cancers (Basel)20260
R0 Resection improves survival after multivisceral resection for pancreatic ductal adenocarcinoma.
PMID 42733466 — adenocarcinoma
iScience20260
Liver perfusion failure after pancreatoduodenectomy: clinical significance and perioperative risk factors.
PMID 42479666 — pancreatic neoplasms, surgical procedures, operative, pancreaticoduodenectomy, transaminases, liver, risk factors, pancreatic fistula, postoperative complications
BJS Open20260
Textbook oncologic outcomes after cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a single-centre cohort analysis.
PMID 42416479 — cytoreduction surgical procedures, hyperthermia, induced, hyperthermic intraperitoneal chemotherapy, reoperation, drug therapy, neoplasm metastasis, chemotherapy, adjuvant, colorectal neoplasms, chemotherapy
Pleura Peritoneum20260

Clinical Studies 26

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 14
Phase 3 6
Phase 1/Phase 2 3
Phase 2 1
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 15
Unknown 6
Terminated 2
Active not recruiting 1
Not yet recruiting 1
Withdrawn 1

By type:

Interventional 24
Observational 2

By Monocentric/Multicentric:

monocentric 15
multicentric2to4 5
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Gastric Venous Reconstruction After Total Pancreatectomy
NCT04850430 — drainage, pancreatic neoplasms, neoplasms, pancreas, gastrectomy, veins, pancreatectomy
N/ANot yet recruiting2024

LeadR Networks

Main global connection map